AstraZeneca Group (AZN)

41.23 +0.05  +0.12%  May 25, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

AstraZeneca Group Valuation

No matter how good a company is, if the price that you pay to buy it is too high, you won't make much money. These valuation metrics should give you a sense of reasonable prices, but be careful with them. Always seek to understand why a valuation is changing over time.

Price Multiples

Price Multiples show how much you get for the price you pay. They can fluctuate drastically over time. Looking at price multiples over time and comparing to those of competitors will help to triangulate a reasonable valuation.

Price to Sales Ratio

Tells you how much you are paying for one dollar of sales.

AZN 1.632
BMY 2.599
LLY 1.984
GSK 2.542

Price to Earnings Ratio

Tells you how much you are paying for one dollar of earnings.

AZN 6.324
BMY 14.84
LLY 10.65
GSK 13.88

Price to Book

Tells you how much you are paying for one dollar of net assets (net assets is total assets - total liabilities).

AZN 2.453
BMY 3.437
LLY 3.218
GSK 7.428

Enterprise Valuation

Enterprise Value (EV) multiples tell you what you would get if you were to buy the whole company (including paying off all debt). Similar to price multiples, they can be compared across time and with peers.

EV / EBITDA Pro

Tells you how much you pay for one dollar of earnings before interest, taxes, depreciation and amortization if you were buying the whole company.

AZN Go Pro
BMY Go Pro
LLY Go Pro
GSK Go Pro

EV / Revenue Pro

Tells you how much you pay for one dollar of sales if you were buying the whole company.

AZN Go Pro
BMY Go Pro
LLY Go Pro
GSK Go Pro

EV / EBIT Pro

Tells you how much you pay for one dollar of earnings before interest and taxes if you were buying the whole company.

AZN Go Pro
BMY Go Pro
LLY Go Pro
GSK Go Pro

EV / Free Cash Flow Pro

Tells how much you are paying for one dollar of current free cash flow if you were buying the whole company.

AZN Go Pro
BMY Go Pro
LLY Go Pro
GSK Go Pro

You may also be interested in these AZN related companies

Get Valuation for
Display in Live Stream: Done
Options

AZN News

$AZN stop at 40 on 1/3. Have owned a ton of it since early '10. Cost basis ~46 (not inc. divies)
about 4 days ago by WallStreetBean
Why U.K. Bonds Are for Losers
May 17, 6:07PM Fool
RT @SeemaCnbc Cancer data expected to move big pharma $JNJ $PFE $AZN
about 10 days ago by StockTwits
$AMRN chat of potential take over target by $AZN for sometimes
about 12 days ago by tradeha
Avoid These 2 Plunging Biotechs
May 14, 5:30PM Fool
$AZN “no longer operating in isolation as a pharmaceutical organization.” http://stks.co/3nwQ
about 14 days ago by WallStreetBean
[$$] 13D Filings
May 12, 4:42AM
6 Flatlining Healthcare Stocks to Sell
May 09, 12:45PM Investor Place
$AMRN and $FRX both are possible acquisition targets for $AZN
about 19 days ago by tradeha
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 20 days ago by abubnic
$AMRN U.K.'s second-biggest drugmaker, pharmaceutical giant $AZN, based in London is sniffing around Ireland's small biotech $AMRN
about 23 days ago by JasonMilano8
$AMRN Bloomberg: Amarin takeover target by AstraZeneca $AZN
about 23 days ago by JasonMilano8
Health Care Sector Wrap
May 03, 4:48PM Fox Business
$AZN popping
about 24 days ago by AltecBX
$AZN a look at last 3 years Annual data: http://stks.co/3cDp
about 26 days ago by WallStreetBean
News related to $AZN, currently +0.3% since open: 'Impax Labs falls on weak sales, new FDA warning' http://stks.co/3bhx
about 26 days ago by TradeBot
what kinda drug is that? RT @JNapodano $AZN reported $16M in sales of Vimovo - not great, but still higher than consensus. $POZN.
about 27 days ago by WallStreetBean
$azn....the yield on this bio just crossed 8.5%....
about 31 days ago by Higreg
$AZN Volume Alert - Currently at 5 x average daily volume.
about 31 days ago by TradeIdeasQuant
5% movers over 10B mkt cap. Up $CTXS $ECA $REGN - Down $AET $AZN $GG Will post charts.
about 31 days ago by TheNumb47
Morning News: April 26, 2012 | via @EddyElfenbein http://stks.co/3Wht $FED $DB $NDX $AAPL $CAT $AZN
about 31 days ago by STNet
$AZN trouble in paradise: AstraZeneca CEO to step down as Q1 profit plunges http://stks.co/3WZ3 (holding)
about 31 days ago by WallStreetBean
News related to $AZN: 'AstraZeneca CEO to step down as Q1 profit plunges' http://stks.co/3WIC
about 32 days ago by TradeBot
$AZN Thurs am eps one of MANY - consensus $1.73 vs 2.03
about 32 days ago by MinervasMomma
$AMRN $azn Will buy $amrn it is just Time 10$ no thanks I will need over 20 to Sell.
about 32 days ago by RqTect
$AMRN $azn does not just want $amrn They need AMRN that is why it is going to $22
about 32 days ago by RqTect
@taketheplunge $AMRN $AZN has been linked to every biotech on the market in the last 3 months. $AZN could buy...
about 32 days ago by jackofalltrade

Recent Quotes

Symbol Price Chg Chg % Market Cap
AZN 41.23 +0.05 +0.12% 53.28B
AZK 4.72 +0.11 +2.39% 769.97M
AZC 1.63 +0.13 +8.67% 235.05M
AYR 11.60 +0.37 +3.29% 839.61M
BCRX 3.26 +0.00 +0.00% 150.09M
BCR 99.90 -0.09 -0.09% 8.473B
BCPC 30.31 -0.25 -0.82% 885.36M
BCOM 4.20 +0.01 +0.24% 125.54M
BCO 23.23 -0.32 -1.36% 1.089B
BCH 84.05 +0.83 +1.00% 12.18B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close